Ironwood Pharmaceuticals, Inc. (IRWD) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Ironwood Pharmaceuticals, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
22.47
Strong
WeakModerateStrong
P/B Ratio
-2.09
Equity Deficit
Earnings Yield
4.39%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
-9.17%
Weak
WeakModerateStrong
Operating Margin
40.10%
Strong
WeakModerateStrong
Net Profit Margin
8.11%
Moderate
WeakModerateStrong
Growth Indicators
2025Revenue Growth
-15.72%
Weak
WeakModerateStrong
Net Income Growth
2629.20%
Strong
WeakModerateStrong
EPS Growth
2627.27%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
1.13
Moderate
WeakModerateStrong
Quick Ratio
1.13
Moderate
WeakModerateStrong
Asset Turnover
0.75x
Moderate
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
23.23%
Strong
WeakModerateStrong
EV / Free Cash Flow
7.31x
Strong
WeakModerateStrong
Net Debt / EBITDA
3.65x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.590
Weak
WeakModerateStrong
Return on Invested Capital
11.39%
Weak
WeakModerateStrong
Cash Conversion Cycle
57.61 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for IRWD.
View Financial Statements